Indication

Chronic iron overload due to repeated blood transfusions

Chronic iron overload due to repeated blood transfusions is an acquired systemic disorder characterized by the progressive accumulation of excess iron in parenchymal tissues, occurring in patients requiring long-term transfusion therapy for chronic refractory anemias such as beta-thalassemia, sickle cell disease, or myelodysplastic syndromes. Read more about Chronic iron overload due to repeated blood transfusions

52 drugs 33 manufacturers

Advertisement

Drugs that treat it

Common Chronic iron overload due to repeated blood transfusions therapies.

Showing 10–18 of 52 drugs

DEFERASIROX

IRON CHELATING AGENTS·CHRONIC IRON OVERLOAD DUE TO REPEATED BLOOD TRANSFUSIONS·+1
Actavis Pharma

DEFERASIROX

IRON CHELATING AGENTS·CHRONIC IRON OVERLOAD DUE TO REPEATED BLOOD TRANSFUSIONS·+1
ASCEND LABORATO

DEFERASIROX

IRON CHELATING AGENTS·CHRONIC IRON OVERLOAD DUE TO REPEATED BLOOD TRANSFUSIONS·+1
ALEMBIC PHARMAC

DEFERASIROX

IRON CHELATING AGENTS·CHRONIC IRON OVERLOAD DUE TO REPEATED BLOOD TRANSFUSIONS·+1
DR.REDDY'S LAB

DEFERASIROX

CHRONIC IRON OVERLOAD DUE TO REPEATED BLOOD TRANSFUSIONS·+1
TEVA USA
Filter & compare in the drug finder →Opens the drug finder with Chronic iron overload due to repeated blood transfusions preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Chronic iron overload due to repeated blood transfusions.

Chronic iron overload due to repeated blood transfusions is an acquired systemic disorder characterized by the progressive accumulation of excess iron in parenchymal tissues, occurring in patients requiring long-term transfusion therapy for chronic refractory anemias such as beta-thalassemia, sickle cell disease, or myelodysplastic syndromes.

Because the human body lacks an active physiologic excretion pathway for excess iron, repeated infusions of donor erythrocytes eventually saturate serum transferrin, resulting in circulating non-transferrin-bound iron.

This unbuffered reactive iron induces cellular oxidative stress and lipid peroxidation, leading to systemic organ injury, predominantly affecting the liver, myocardium, and endocrine glands.

If left untreated, the cumulative toxicity can cause severe end-organ complications, including hepatic fibrosis or cirrhosis, cardiac dysrhythmias and heart failure, and multiple endocrinopathies such as diabetes mellitus and hypogonadism.

Personalize your experience

Follow Chronic iron overload due to repeated blood transfusions and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it